ジョージア州における骨肉腫の臨床試験
ジョージア州内の拠点で、骨肉腫に関する10件の研究が参加者を募集しています。
ジョージア州内の都市
公式研究テキスト（英語）
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
- Chilldren's Healthcare of Atlanta, Atlanta
被験者募集中第1相
50歳以下 · 全性別 · 2026/09/30更新 · NCT06492954Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
被験者募集中第2相
12歳〜39歳 · 全性別 · 2026/09/29更新 · NCT04616560Losartan + Sunitinib in Treatment of Osteosarcoma
- Children's Hospital of Atlanta, Atlanta
被験者募集中第1相
10歳以上 · 全性別 · 2026/09/01更新 · NCT03900793Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
被験者募集中第3相
50歳以下 · 全性別 · 2026/08/25更新 · NCT05235165Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Children's Healthcare of Atlanta, Atlanta
被験者募集中第1/2相
30歳以下 · 全性別 · 2026/08/03更新 · NCT06239272Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
- Arthur M. Blank Children's Healthcare of Atlanta, Atlanta
被験者募集中第1相
1歳〜30歳 · 全性別 · 2026/06/02更新 · NCT07144254Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/05/19更新 · NCT04901702Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Children's Healthcare of Atlanta - Egleston, Atlanta
被験者募集中観察研究
全年齢 · 全性別 · 2026/05/18更新 · NCT01790152Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
- Children's Healthcare of Atlanta, Atlanta
被験者募集中第1相
12 Months · 全性別 · 2025/12/26更新 · NCT05400603ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。